Article
Construction of a novel constitutively active chimeric EGFR to identify new targets for therapy.
Neoplasia (New York, N.Y.) - 1 Dec 2005
Cheng Hua, Langley Robert R, Wu Qiuyu, Wu Wenjuan, Feng Jie, Tsan Rachel, Fan Dominic, Fidler Isaiah J
Abstract excerpt
Tumor cells and tumor-associated endothelial cells express activated epidermal growth factor receptor (EGFR) due to production of EGF-related ligands in the tumor microenvironment. To investigate the effect of perpetual EGFR activation on endothelial cells, we developed a novel method to generate constitutively active EGFR. We fused the entire intracellular domain of the EGFR to the N-terminus of the CD3zeta...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
